TEVA icon

Teva Pharmaceuticals
TEVA

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$26
31% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
JP Morgan
JP Morgan
Chris Schott
50% 1-yr TEVA win rate
3 Oct ‘25 12 days ago
UBS
UBS
Ashwani Verma
50% 1-yr TEVA win rate
24 Sep ‘25 21 days ago